Federico Grossi - Net Worth and Insider Trading

Federico Grossi Net Worth

The estimated net worth of Federico Grossi is at least $2 Million dollars as of 2025-05-03. Federico Grossi is the Chief Medical Officer of Apellis Pharmaceuticals Inc and owns about 94,884 shares of Apellis Pharmaceuticals Inc (APLS) stock worth over $2 Million. Details can be seen in Federico Grossi's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Federico Grossi has not made any transactions after 2023-01-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of Federico Grossi

To

Federico Grossi Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Federico Grossi owns 1 companies in total, including Apellis Pharmaceuticals Inc (APLS) .

Click here to see the complete history of Federico Grossi’s form 4 insider trades.

Insider Ownership Summary of Federico Grossi

Ticker Company Transaction Date Type of Owner
APLS Apellis Pharmaceuticals Inc 2023-01-05 See Remarks

Federico Grossi Latest Holdings Summary

Federico Grossi currently owns a total of 1 stock. Federico Grossi owns 94,884 shares of Apellis Pharmaceuticals Inc (APLS) as of January 5, 2023, with a value of $2 Million.

Latest Holdings of Federico Grossi

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
APLS Apellis Pharmaceuticals Inc 2023-01-05 94,884 20.34 1,929,941

Holding Weightings of Federico Grossi


Federico Grossi Form 4 Trading Tracker

According to the SEC Form 4 filings, Federico Grossi has made a total of 37 transactions in Apellis Pharmaceuticals Inc (APLS) over the past 5 years, including 0 buys and 37 sells. The most-recent trade in Apellis Pharmaceuticals Inc is the sale of 2,500 shares on January 5, 2023, which brought Federico Grossi around $121,975.

Insider Trading History of Federico Grossi

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Federico Grossi Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Federico Grossi Ownership Network

Ownership Network List of Federico Grossi

No Data

Ownership Network Relation of Federico Grossi

Insider Network Chart


Federico Grossi Owned Company Details

What does Apellis Pharmaceuticals Inc do?

Who are the key executives at Apellis Pharmaceuticals Inc?

Federico Grossi is the See Remarks of Apellis Pharmaceuticals Inc. Other key executives at Apellis Pharmaceuticals Inc include See Remarks James George Chopas , General Counsel David O. Watson , and Senior Vice President Mark Jeffrey Delong .

Apellis Pharmaceuticals Inc (APLS) Insider Trades Summary

Over the past 18 months, Federico Grossi made no insider transaction in Apellis Pharmaceuticals Inc (APLS). Other recent insider transactions involving Apellis Pharmaceuticals Inc (APLS) include a net sale of 244,500 shares made by Pascal Deschatelets , a net sale of 35,769 shares made by David O. Watson , and a net sale of 311,716 shares made by Cedric Francois .

In summary, during the past 3 months, insiders sold 6,115 shares of Apellis Pharmaceuticals Inc (APLS) in total and bought 0 shares, with a net sale of 6,115 shares. During the past 18 months, 982,400 shares of Apellis Pharmaceuticals Inc (APLS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 982,400 shares.

Apellis Pharmaceuticals Inc (APLS)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Apellis Pharmaceuticals Inc Insider Transactions

No Available Data

Federico Grossi Mailing Address

Above is the net worth, insider trading, and ownership report for Federico Grossi. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Federico Grossi's mailing address is: Crestwood Ky 40014.